Chemotherapy intensification for first-line treatment of poor-prognosis metastatic germ cell cancer is not yet ready for prime time

  • Di Maria Jiang
  • Robert J. Hamilton
  • Aaron R. Hansen
Keywords: Chemotherapy intensification, standard of care, poor-risk non-seminomatous germ cell tumor
Published
2020-01-30
How to Cite
Jiang, D. M., Hamilton, R. J., & Hansen, A. R. (2020). Chemotherapy intensification for first-line treatment of poor-prognosis metastatic germ cell cancer is not yet ready for prime time . Canadian Urological Association Journal, 14(2), 48-9. https://doi.org/10.5489/cuaj.6407
Section
Commentary